A long-range comprehensive program is proposed for study of the structure, function, and genetic control of a series of inadequately characterized human plasma proteins, principally alpha-glycoproteins and beta-glycoproteins. Some have identified function and clinical significance and others not, but in no case is much known about their structure. Emphasis will be on determination of the amino acid sequence, disulfide bonding pattern, localization and kind of carbohydrate groups, and the combining sites of ligands such as metal ions and heme. Correlation of function and structure will be sought, and interrelationships with other plasma proteins will be investigated. Some correlations will be done in cooperation with other groups studying changes in plasma proteins in disease, their genetic polymorphism and variation, their metabolism and membrane uptake, and their three-dimensional structure. The first proteins selected for study are ceruloplasmin, a copper-containing protein with ferroxidase activity that is involved in copper metabolism and beta-glycoprotein I, a crystallizable protein of high carbohydrate content and of unknown function. Proteins under exploratory study for future investigation include: 1) the heme-binding protein hemopexin, 2) the histidine-rich alpha 2-glycoprotein that binds both heme and divalent metals, and 3) angiotensinogen (renin substrate) the precusor of angiotensin, a pressor substance probably involved in hypertension. The long range goals are to make a major contribution to knowledge about human plasma proteins, to integrate information gained from in vitro study with in vivo function, and to focus attention on characterization, quantitation, and clinical significance of this group of proteins from human blood plasma. The methods to be used include amino acid and carbohydrate analysis, amino acid sequence anlysis, immunochemical and physicochemical characterization, nuclear magnetic resonance spectroscopy, circular dichroism, and other procedures for structural study of proteins and carbohydrates.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM019221-10
Application #
3151199
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1976-05-01
Project End
1986-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
10
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Indiana University Bloomington
Department
Type
Schools of Arts and Sciences
DUNS #
006046700
City
Bloomington
State
IN
Country
United States
Zip Code
47402
Takahashi, N; Takahashi, Y; Putnam, F W (1986) Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta. Proc Natl Acad Sci U S A 83:8019-23
Ishioka, N; Takahashi, N; Putnam, F W (1986) Amino acid sequence of human plasma alpha 1B-glycoprotein: homology to the immunoglobulin supergene family. Proc Natl Acad Sci U S A 83:2363-7
Takahashi, N; Takahashi, Y; Ishioka, N et al. (1986) Application of an automated tandem high-performance liquid chromatographic system to peptide mapping of genetic variants of human serum albumin. J Chromatogr 359:181-91
Takahashi, N; Takahashi, Y; Putnam, F W (1985) Complete amino acid sequence of human hemopexin, the heme-binding protein of serum. Proc Natl Acad Sci U S A 82:73-7
Takahashi, N; Ishioka, N; Takahashi, Y et al. (1985) Automated tandem high-performance liquid chromatographic system for separation of extremely complex peptide mixtures. J Chromatogr 326:407-18
Takahashi, N; Takahashi, Y; Putnam, F W (1985) Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc Natl Acad Sci U S A 82:1906-10